Exodus Point Capital Management, LP Bluebird Bio, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,296,668 shares of BLUE stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,296,668Holding current value
$10.1 Million% of portfolio
0.0%Shares
15 transactions
Others Institutions Holding BLUE
# of Institutions
150Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$81.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$36.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$36.4 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$29.9 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $601M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...